Cite
Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis.
MLA
Mao-hua Zheng, et al. “Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis.” BioMed Research International, vol. 2016, Jan. 2016, pp. 1–9. EBSCOhost, https://doi.org/10.1155/2016/5807346.
APA
Mao-hua Zheng, Hong-tao Sun, Ji-guang Xu, Gang Yang, Lei-ming Huo, Pan Zhang, Jin-hui Tian, & Ke-hu Yang. (2016). Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis. BioMed Research International, 2016, 1–9. https://doi.org/10.1155/2016/5807346
Chicago
Mao-hua Zheng, Hong-tao Sun, Ji-guang Xu, Gang Yang, Lei-ming Huo, Pan Zhang, Jin-hui Tian, and Ke-hu Yang. 2016. “Combining Whole-Brain Radiotherapy with Gefitinib/Erlotinib for Brain Metastases from Non-Small-Cell Lung Cancer: A Meta-Analysis.” BioMed Research International 2016 (January): 1–9. doi:10.1155/2016/5807346.